Immunitybio Inc (NQ: IBRX )
5.790
-0.190
(-3.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Press Releases about Immunitybio Inc![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via TheNewswire.com
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via NewMediaWire
Topics
Lawsuit
NASDAQ: IBRX Shareholder Alert: Lawsuit Alleges Misleading Statements by ImmunityBio, Inc.
August 10, 2023
Via SBWire
Topics
Lawsuit
![]() ![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]()
ImmunityBio Names Enrique Diloné as Chief Technology Officer
August 03, 2023
From ImmunityBio, Inc.
Via Business Wire
![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.